INDS Logo   Integrated Nonclinical Development Solutions, Inc.
Send Explorer Logo

Single Study Visualizations

Summary View for Numeric Data

…to visualize patterns and trends in numeric data with summary statistics, scatterplot, out of concurrent control range indicator, and % control mean calculations

Summary View Detail

…to review thumbnail visualizations or display detailed view showing distribution of subject data across groups

Severity Heatmap

…to visualize patterns and trends in both incidence and severity

Cross-Domain Subject View

…to put a subject’s data into perspective as compared to its own group and control group, on a single day or over time


Send Explorer Plus Logo

Multi-Study Visualizations

Correlations Matrix

…to reveal pairwise correlations of endpoints for selected subjects, identifying those with histopathology findings in tissues of interest.

Multi-Study Timecourse Grid

…to compare the timecourse pattern of selected endpoint(s) across studies of interest.

Histopathology Treemap

…to visualize relative prevalence of histopathology findings across studies.

Historical Control Distribution

…to reveal the distribution of selected control data across studies, stratified by fields of interest.


The INDS Advantage

The specialized, complementary expertise of our team members enables INDS to provide you drug development support from target selection to product registration. Our data management and information technology specialists work closely with our toxicologists to deliver software solutions that truly reflect end-user needs for ease-of-use and flexibility. Our team consists of board certified toxicologists, veterinarians, and information technology and business operations experts with more than 100 years of combined experience in the pharmaceutical and contract research industries.

Our Experience

  • Advancing over 120 compounds in all major therapeutic areas to clinical trials, using both traditional and alternative paradigms, including filing industry’s first exploratory IND.
  • Advancing compounds to market, including several first-in-class drugs (Cognex®, ReZulin®, Neurontin®, LYRICA®) and the world’s best selling drug Lipitor®, through design and execution of standard studies and extensive mechanistic investigations.
  • Developing innovative informatics solutions including state-of-the-art data warehousing, data visualization, interpretations and automated reporting tools.
  • Integrating and implementing SEND 3.0.

Committed To Your Success

Whether you lack internal safety expertise or need to supplement your internal resources to meet peak demands, contact INDS. We have the know-how you need to succeed.